These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6084121)

  • 21. Preliminary clinical trial with a new hypotensive, guanabenz, in a group of hypertensive patients.
    De Ridder JH; Marchandise P
    Acta Cardiol; 1980; 35(5):349-55. PubMed ID: 6970485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of guanabenz on blood pressure responses to posture and exercise.
    Dziedzic SW; Elijovich F; Felton K; Yeager K; Krakoff LR
    Clin Pharmacol Ther; 1983 Feb; 33(2):151-5. PubMed ID: 6337003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of guanabenz on arterial pressure and the renin-aldosterone system in hypertensive patients].
    Rappelli A; Glorioso N; Tedde R; Madeddu P; Dessì Fulgheri P; Campus S
    Boll Soc Ital Cardiol; 1978; 23(1):177-83. PubMed ID: 754771
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and fundamental study of guanabenz in hypertensive patients with renal failure].
    Nishio S; Hayashi S; Yoshihara H
    Hinyokika Kiyo; 1988 Jun; 34(6):1083-9. PubMed ID: 3223454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of guanabenz, alpha 2 central agonist, on the activity of the sympathetic nervous system during dynamic and isometric physical exercise].
    Fariello R; Agabiti-Rosei E; Alicandri C; Romanelli G; Muiesan G; Renzetti I
    Minerva Cardioangiol; 1984 May; 32(5):273-9. PubMed ID: 6382054
    [No Abstract]   [Full Text] [Related]  

  • 26. Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension.
    Rosendorff C
    S Afr Med J; 1982 Sep; 62(13):435-7. PubMed ID: 7051365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guanabenz effects on blood pressure and noninvasive parameters of cardiac performance in patients with hypertension.
    Shah RS; Walker BR; Vanov SK; Helfant RH
    Clin Pharmacol Ther; 1976 Jun; 19(6):732-7. PubMed ID: 773584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Guanabenz acetate and serum lipids. Sequential evaluation during one year].
    Spritzer N; Spritzer TS; Rodrigues R
    Arq Bras Cardiol; 1988 Aug; 51(2):193-7. PubMed ID: 3075114
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship of guanabenz concentrations in brain and plasma to antihypertensive effect in the spontaneously hypertensive rat.
    Meacham RH; Ruelius HW; Kick CJ; Peters JR; Kocmund SM; Sisenwine SF; Wendt RL
    J Pharmacol Exp Ther; 1980 Sep; 214(3):594-8. PubMed ID: 7400962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a centrally acting antihypertensive agent and beta-adrenergic blocking agents for the treatment of hypertension.
    Morgan TO
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S808-13. PubMed ID: 6084130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of arterial hypertension with a new drug combining guanabenz-mefruside].
    Frisina N; Macrì I; Ussi F
    Minerva Cardioangiol; 1984 May; 32(5):325-32. PubMed ID: 6382057
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of idiopathic hypertension with guanabenz-mefruside].
    Tomasi AM; Pirani R; Masoni C
    Minerva Cardioangiol; 1984 May; 32(5):339-44. PubMed ID: 6382059
    [No Abstract]   [Full Text] [Related]  

  • 33. Withdrawal syndrome following cessation of guanabenz therapy.
    Ram CV; Holland OB; Fairchild C; Gomez-Sanchez CE
    J Clin Pharmacol; 1979; 19(2-3):148-50. PubMed ID: 422739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of guanabenz withdrawal on blood pressure and plasma catecholamines.
    Buckalew VM; Burgess R; Strandhoy JW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S830-2. PubMed ID: 6084134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of guanabenz and hydrochlorothiazide on blood pressure and plasma renin activity.
    Holland OB; Fairchild C; Gomez-Sanchez CE
    J Clin Pharmacol; 1981 Apr; 21(4):133-9. PubMed ID: 7016928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of guanabenz and hydrochlorothiazide on plasma lipids.
    Kaplan NM; Grundy S
    Clin Pharmacol Ther; 1988 Sep; 44(3):297-302. PubMed ID: 3046814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guanabenz (Wytensin) a new antihypertensive drug.
    Med Lett Drugs Ther; 1983 Jan; 25(627):11-2. PubMed ID: 6336818
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of guanabenz on plasma lipid levels in hypertensive patients.
    Kaplan NM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S841-6. PubMed ID: 6084137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal effects of guanabenz: a new antihypertensive.
    Bosanac P; Dubb J; Walker B; Goldberg M; Agus ZS
    J Clin Pharmacol; 1976; 16(11-12):631-6. PubMed ID: 993358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of guanabenz alone and in association with a diuretic on blood pressure and on the renin-angiotensin-aldosterone system in hypertensive patients].
    Madeddu P; Glorioso N; Dessì-Fulgheri P; Rappelli A; Delle Gemme E
    Minerva Cardioangiol; 1984 May; 32(5):281-4. PubMed ID: 6382055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.